Jacquelyn Laplant
Ophthalmology · Milwaukee, WINPI 1033572375
Payments from drug & device makers
Across 27 payments — averaging $86.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$1K
- Amgen$275
- AbbVie$228
- Penumbra, Inc.$170
- Aerie Pharmaceuticals, Inc.$103
- Johnson & Johnson$85
- plus $128 from 4 others
What the payments were for
- Travel & lodging$1,35058%
- Food & beverage$98942%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 1 | $1,350 |
| Amgen | 11 | $275 |
| AbbVie | 6 | $228 |
| Penumbra, Inc. | 1 | $170 |
| Aerie Pharmaceuticals, Inc. | 1 | $103 |
| Johnson & Johnson | 2 | $85 |
| Alcon | 2 | $69 |
| Genentech USA, Inc. | 1 | $23 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $21 |
| Genentech, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Penumbra Coil 400$170
- TEPEZZA$124
- Rocklatan$103
- Rhopressa$103
How this compares
$2,339 in reported general payments places this provider in the 80th percentile of 337 ophthalmology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ErythromycinErythromycin Base | 149 | $1,648 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 103 | $1,199 |
| Doxycycline Hyclate | 44 | $850 |
| Methylprednisolone | 41 | $277 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $20 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Milwaukee
- William WirostkoMilwaukee$46K
- Dennis HanMilwaukee$8K
- Charles YangMilwaukee$6K
- Michael RacitiMilwaukee$6K
- Monica Gonzalez-CollazoMilwaukee$5K
- Sarah CarballoMilwaukee$4K
- Marc HirschMilwaukee$3K
- Smith Ann ChisholmMilwaukee$3K
- Nicholas FrameMilwaukee$3K
- Inder SinghRacine$3.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.